Join us at the cutting edge of oncology innovation. In this role, you will immerse yourself in the exciting and innovative field of liquid-biopsy based biomarker investigation in oncology with direct application to our internal project’s portfolio. Liquid biopsies represent a major advance in the molecular diagnostic space and are increasingly used in clinical trials. By replacing invasive tissue biopsies with minimally invasive blood sampling, They facilitate patient recruitment, enable earlier assessment of treatment response, and improve identification of appropriate patient populations. In addition, they provide valuable insight into disease biology and support the development of predictive and prognostic biomarkers. Debiopharm is now expanding the implementation of these technologies across our portfolio. As an intern in the Personalised Medicine team, part of the Translation Medicine Team, you will participate in fore-front clinical investigations, contribute directly to patient-centric clinical trials design and help shape the future of targeted oncology therapies. RequirementsWorking under the guidance and mentorship of an Associate Principal Scientist, your core responsibilities will be but not limited to: perform advanced data analyses on liquid biopsy sequencing results and propose additional investigations drive the integration of liquid biopsy approaches within the context of our portfolio, provide input into the clinical trial protocols support internal advocacy for the adoption of liquid biopsy technologies within project teams and management support the definition and implementation of biomarker strategies where liquid biopsy data are critical Your profile PhD in Life sciences, molecular biology, genetics, or a related discipline Experience in large datasets analysis Comfortable with using basic bioinformatic tools Previous experience with molecular diagnostic assays is an asset Ready to work in cross-functional team and fast-paced environment A collaborative spirit, looking to tackle new challenges Excellent communication skills in English (oral and written) BenefitsWhat we Offer: Being part of a company where innovation, collaboration, and impact aren’t just values — they’re how we work every day Partner with teams across disciplines, at the forefront of oncology and anti-infective development An inclusive and respectful workplace — proud to be Equal-Pay certified Grow in a culture that values people, purpose, and performance A chance to grow, share, and shape the future of healthcare What to Expect in the Recruitment Process: If your application is selected, you’ll be invited to interviews with Talent Acquisition and the Hiring Manager via Teams, followed by a panel interview and reference checks. Communication is handled via Workable—check your spam folder for emails from *@outbound.workable.com. We do not accept unsolicited applications from agencies or recruiters.
Join us at the cutting edge of oncology innovation. In this role, you will immerse yourself in the exciting and innovative field of liquid-biopsy based biomarker investigation in oncology with direct application to our internal project’s portfolio.
Liquid biopsies represent a major advance in the molecular diagnostic space and are increasingly used in clinical trials. By replacing invasive tissue biopsies with minimally invasive blood sampling, They facilitate patient recruitment, enable earlier assessment of treatment response, and improve identification of appropriate patient populations. In addition, they provide valuable insight into disease biology and support the development of predictive and prognostic biomarkers. Debiopharm is now expanding the implementation of these technologies across our portfolio.
As an intern in the Personalised Medicine team, part of the Translation Medicine Team, you will participate in fore-front clinical investigations, contribute directly to patient-centric clinical trials design and help shape the future of targeted oncology therapies.
Requirements
Working under the guidance and mentorship of an Associate Principal Scientist, your core responsibilities will be but not limited to:
- perform advanced data analyses on liquid biopsy sequencing results and propose additional investigations
- drive the integration of liquid biopsy approaches within the context of our portfolio, provide input into the clinical trial protocols
- support internal advocacy for the adoption of liquid biopsy technologies within project teams and management
- support the definition and implementation of biomarker strategies where liquid biopsy data are critical
Your profile
- PhD in Life sciences, molecular biology, genetics, or a related discipline
- Experience in large datasets analysis
- Comfortable with using basic bioinformatic tools
- Previous experience with molecular diagnostic assays is an asset
- Ready to work in cross-functional team and fast-paced environment
- A collaborative spirit, looking to tackle new challenges
- Excellent communication skills in English (oral and written)
Benefits
What we Offer:
- Being part of a company where innovation, collaboration, and impact aren’t just values — they’re how we work every day
- Partner with teams across disciplines, at the forefront of oncology and anti-infective development
- An inclusive and respectful workplace — proud to be Equal-Pay certified
- Grow in a culture that values people, purpose, and performance
- A chance to grow, share, and shape the future of healthcare
What to Expect in the Recruitment Process:
If your application is selected, you’ll be invited to interviews with Talent Acquisition and the Hiring Manager via Teams, followed by a panel interview and reference checks. Communication is handled via Workable—check your spam folder for emails from *@outbound.workable.com.
We do not accept unsolicited applications from agencies or recruiters.
Debiopharm is an independent biopharmaceutical company based in Switzerland with headquarters in Lausanne(VD) and a manufacturing site in Martigny (VS).We are committed to developing innovative therapies that target high unmet medical needs in oncology and infectious diseases with a broad range of expertise in drug development, drug manufacturing as well as investment in start-ups. Through our unique business model, we identify high-potential compounds and technologies for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
Debiopharm is an independent biopharmaceutical company based in Switzerland with headquarters in Lausanne(VD) and a manufacturing site in Martigny (VS).
We are committed to developing innovative therapies that target high unmet medical needs in oncology and infectious diseases with a broad range of expertise in drug development, drug manufacturing as well as investment in start-ups.
Through our unique business model, we identify high-potential compounds and technologies for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
